Profiel
James R.
Piggott has been Senior Vice President of Pharmaceutical Biology for Lexicon Pharmaceuticals, Inc. since January 2000.
From 1990 to October 1999, he worked at ZymoGenetics, Inc., most recently as Senior Vice President-Research Biology from 1997 to October 1999.
Previously, Dr. Piggott worked at the Smith Kline & French Laboratories Ltd.
and the GD Searle & Co. He received a BA degree and a PhD from Trinity College.
Eerdere bekende functies van James R. Piggott
Bedrijven | Functie | Einde |
---|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 01-10-1999 |
LEXICON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Opleiding van James R. Piggott
Trinity College Dublin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
LEXICON PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |